OBJECTIVES: Helicobacter pylori (H. pylori) chronically infects the human stomach and may cause extra-gastrointestinal diseases. The role of H. pylori in the pathogenesis of atherosclerosis and its effect on lipids remains controversial. The aim of this study was to examine lipid levels in patients with and without H. pylori infection. METHODS: A total of 244 consecutive patients who underwent esophagogastroduodenoscopy were included in this study. Patients receiving statin and fibrate therapy and diabetic patients were excluded. Biopsies from each individual were taken and analyzed for H. pylori detection using ultrastructural methods. Patients were divided into two groups: H. pylori (+) (group 1) and H. pylori (-) (group 2). Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride levels were measured in all subjects. RESULTS: A total of 163 patients were included in group 1 and 81 patients were included in group 2. Frequency of H. pylori was 67% in the study population. Total cholesterol (204 +/- 39 mg/dl versus 189 +/- 42 mg/dl, respectively; P = 0.007) and LDL-C (128 +/- 30 mg/dl versus 116 +/- 32 mg/dl, respectively; P = 0.003) were significantly higher in group 1 than in group 2. Updated Sydney classification score showed a positive correlation with LDL-C (r = 0.333, P < 0.001) and TC (r = 0.288, P < 0.001) levels. CONCLUSION: Increased levels of TC and LDL-C were found in patients infected with H. pylori, and updated Sydney System score showed a positive correlation with LDL-C and TC levels. These findings may explain why H. pylori infection is associated with increased risk of atherosclerosis.
OBJECTIVES:Helicobacter pylori (H. pylori) chronically infects the human stomach and may cause extra-gastrointestinal diseases. The role of H. pylori in the pathogenesis of atherosclerosis and its effect on lipids remains controversial. The aim of this study was to examine lipid levels in patients with and without H. pyloriinfection. METHODS: A total of 244 consecutive patients who underwent esophagogastroduodenoscopy were included in this study. Patients receiving statin and fibrate therapy and diabeticpatients were excluded. Biopsies from each individual were taken and analyzed for H. pylori detection using ultrastructural methods. Patients were divided into two groups: H. pylori (+) (group 1) and H. pylori (-) (group 2). Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride levels were measured in all subjects. RESULTS: A total of 163 patients were included in group 1 and 81 patients were included in group 2. Frequency of H. pylori was 67% in the study population. Total cholesterol (204 +/- 39 mg/dl versus 189 +/- 42 mg/dl, respectively; P = 0.007) and LDL-C (128 +/- 30 mg/dl versus 116 +/- 32 mg/dl, respectively; P = 0.003) were significantly higher in group 1 than in group 2. Updated Sydney classification score showed a positive correlation with LDL-C (r = 0.333, P < 0.001) and TC (r = 0.288, P < 0.001) levels. CONCLUSION: Increased levels of TC and LDL-C were found in patients infected with H. pylori, and updated Sydney System score showed a positive correlation with LDL-C and TC levels. These findings may explain why H. pyloriinfection is associated with increased risk of atherosclerosis.
Authors: A Hoffmeister; D Rothenbacher; G Bode; K Persson; W März; M A Nauck; H Brenner; V Hombach; W Koenig Journal: Arterioscler Thromb Vasc Biol Date: 2001-03 Impact factor: 8.311
Authors: Jianhui Zhu; Arshed A Quyyumi; Joseph B Muhlestein; F Javier Nieto; Benjamin D Horne; Alexandra Zalles-Ganley; Jeffrey L Anderson; Stephen E Epstein Journal: Am J Cardiol Date: 2002-01-15 Impact factor: 2.778
Authors: Winfried März; Hubert Scharnagl; Karl Winkler; Andreas Tiran; Markus Nauck; Bernhard O Boehm; Bernhard R Winkelmann Journal: Circulation Date: 2004-10-25 Impact factor: 29.690
Authors: Mehmet Aslan; Yasar Nazligul; Mehmet Horoz; Cengiz Bolukbas; Fusun F Bolukbas; Mustafa Gur; Hakim Celik; Ozcan Erel Journal: Atherosclerosis Date: 2006-11-27 Impact factor: 5.162
Authors: Hack-Lyoung Kim; Han Ho Jeon; In Young Park; Jin Man Choi; Ji Sun Kang; Kyueng-Whan Min Journal: J Korean Med Sci Date: 2011-04-21 Impact factor: 2.153
Authors: Melanie L Hutton; Kimberley D'Costa; Amanda E Rossiter; Lin Wang; Lorinda Turner; David L Steer; Seth L Masters; Ben A Croker; Maria Kaparakis-Liaskos; Richard L Ferrero Journal: Front Cell Infect Microbiol Date: 2017-06-06 Impact factor: 5.293